levodopa has been researched along with Polyneuropathies in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.45) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (10.34) | 29.6817 |
2010's | 18 (62.07) | 24.3611 |
2020's | 7 (24.14) | 2.80 |
Authors | Studies |
---|---|
Eerola-Rautio, J; Koivu, M; Pauls, KAM; Pekkonen, E; Toppila, J; Udd, M | 1 |
Dulski, J; Piekarski, R; Roszmann, A; Sławek, J | 2 |
Bonno, D; Bouchard, M; Canissario, R; Déry, C; Dupré, N; Lang, AE; Lizarraga, KJ; Logigian, E; McDermott, MP; Modica, JS; Stanton, M | 1 |
Finsterer, J | 1 |
Abe, K; Chan, CC; Chao, CC; Chen, ML; Cheng, J; Daida, K; Farrer, M; Funayama, M; Hattori, N; Hsieh, ST; Huang, CY; Hung, YC; Jeon, B; Ke, YC; Lai, HJ; Lee, NC; Li, Y; Lin, CH; Lin, HY; Lo, WC; Mukai, Y; Nishioka, K; Sato, K; Takahashi, Y; Tsai, HH; Tsai, PI; Tzeng, SR; Wu, RM; Wu, YS; Yen, RF; Yoshino, H | 1 |
Ou, Z; Tong, Q; Wang, L; Xue, L; Zheng, J | 1 |
Coraci, D; Giovannini, S; Imbimbo, I; Padua, L; Santilli, V | 1 |
Bove, F; Di Iorio, R; Fasano, A; Gallicchio, L; Luigetti, M; Petruzzellis, A; Recchia, V; Tamma, F | 1 |
Andréasson, M; Brodin, L; Laffita-Mesa, JM; Svenningsson, P | 1 |
Andersohn, F; Chatamra, K; Conradt, C; Guo, D; Ismail, C; Miclea, A; Nisslein, T | 1 |
Benesh, J; Boyd, JT; Chatamra, K; Eaton, S; Espay, AJ; Facheris, MF; Fernandez, HH; Fung, VSC; Hall, C; Lew, MF; Robieson, WZ; Rodriguez, RL; Slevin, JT; Standaert, DG; Vanagunas, AD; Zadikoff, C | 1 |
Čierny, D; Grofik, M; Kurča, E; Michalik, J; Nosáľ, V; Sivák, Š; Tatarková, Z; Turčanová Koprušáková, M | 1 |
Blumbergs, P; Kimber, T; Thompson, P | 1 |
Ehlen, F; Jugel, C; Klostermann, F; Marzinzik, F; Müller, T; Taskin, B | 1 |
Ceballos-Baumann, AO; Fietzek, UM; Lehnerer, SM; Messner, M | 1 |
Cai, H; Matsubara, S; Mukai, M; Nakano, I; Sasaki, H; Sugaya, K; Yabe, I | 1 |
Eleopra, R; Onofrj, M; Uncini, A | 1 |
Dziewiatowski, K; Robowski, P; Schinwelski, M; Sitek, E; Szabat, K; Szadejko, K; Sławek, J | 1 |
Beer, S; Möller, JC; Mylius, V; Schepelmann, K; Teepker, M; Zouari, HG | 1 |
Bonanni, L; Cossu, G; Manca, D; Onofrj, M; Stocchi, F; Thomas, A | 1 |
Danton, AC; Durrieu, G; Lacroix, I; Montastruc, JL; Olivier, P; Senard, JM; Sommet, A | 1 |
Lanzillo, B; Nolano, M; Provitera, V; Santoro, L | 1 |
Jugel, C; Klostermann, F; Marzinzik, F; Müller, T | 1 |
Carrillo, F; Casanova, J; De Fabregues, O; de la Fuente-Fernández, R; Grande, M; Mir, P; Palasí, A; Santos-García, D; Valldeoriola, F | 1 |
Choo, YM; Lim, SY; Mahamad, UA; Marras, C; Shahrizaila, N; Yap, AC | 1 |
Eisensehr, I | 1 |
Bleich, S; Degner, D; Poser, W; Riegel, A; Rüther, E; Sprung, R | 1 |
Shahani, BT; Young, RR | 1 |
7 review(s) available for levodopa and Polyneuropathies
Article | Year |
---|---|
Acute/subacutae demyelinating polyneuropathy in Parkinson's Disease patients on levodopa-carbidopa intestinal gel therapy: systematic review with new case report.
Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Gels; Humans; Levodopa; Parkinson Disease; Polyneuropathies; Prospective Studies | 2023 |
A systematic review of the potential consequences of abnormal serum levels of vitamin B6 in people living with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Carbidopa; Epilepsy; Humans; Levodopa; Parkinson Disease; Polyneuropathies; Vitamin B 12; Vitamin B 6; Vitamins | 2023 |
[Familial progressive external opthalmoplegia, parkinsonism and polyneuropathy associated with POLG1 mutation].
Topics: Aged; DNA Polymerase gamma; DNA-Directed DNA Polymerase; DNA, Mitochondrial; Female; Gene Deletion; Genes, Dominant; Humans; Levodopa; Male; Menopause, Premature; Mitochondrial Diseases; Muscular Diseases; Mutation; Ophthalmoplegia, Chronic Progressive External; Parkinsonian Disorders; Pedigree; Polyneuropathies; Syndrome | 2014 |
Polyneuropathy associated with duodenal infusion of levodopa in Parkinson's disease: features, pathogenesis and management.
Topics: Administration, Oral; Carbidopa; Drug Combinations; Female; Gels; Humans; Levodopa; Parkinson Disease; Polyneuropathies; Vitamin B 12 | 2015 |
Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment.
Topics: Antiparkinson Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinsonian Disorders; Polyneuropathies | 2009 |
Polyneuropathy while on duodenal levodopa infusion in Parkinson's disease patients: we must be alert.
Topics: Aged; Aged, 80 and over; Duodenum; Female; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Parkinson Disease; Polyneuropathies; Vitamin B 12 Deficiency | 2012 |
[Paraesthesia in the legs].
Topics: Analgesics, Opioid; Diagnosis, Differential; Dopamine Agents; Humans; Levodopa; Nocturnal Myoclonus Syndrome; Paresthesia; Polyneuropathies; Psychomotor Agitation; Restless Legs Syndrome; Sleep-Wake Transition Disorders; Venous Insufficiency | 2007 |
1 trial(s) available for levodopa and Polyneuropathies
Article | Year |
---|---|
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Compulsive Behavior; Double-Blind Method; Drug Combinations; Female; Gels; Humans; International Cooperation; Intestines; Levodopa; Longitudinal Studies; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Polyneuropathies; Weight Loss | 2018 |
21 other study(ies) available for levodopa and Polyneuropathies
Article | Year |
---|---|
Polyneuropathy monitoring in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel.
Topics: Antiparkinson Agents; Carbidopa; Gels; Humans; Levodopa; Parkinson Disease; Polyneuropathies | 2021 |
Before blaming levodopa/carbidopa intestinal gel for demyelinating polyneuropathy, all differential aetiologies must be ruled out.
Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Humans; Levodopa; Parkinson Disease; Polyneuropathies | 2023 |
Response to 'Before blaming levodopa/carbidopa intestinal gel for demyelinating polyneuropathy, all differential aetiologies must be ruled out'.
Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Humans; Levodopa; Parkinson Disease; Polyneuropathies | 2023 |
Mitochondrial UQCRC1 mutations cause autosomal dominant parkinsonism with polyneuropathy.
Topics: Age of Onset; Aged; Animals; Antiparkinson Agents; Cell Line; Chromosome Aberrations; Drosophila; Electron Transport Complex III; Exome Sequencing; Female; Frameshift Mutation; Gene Knock-In Techniques; Genes, Dominant; Humans; Levodopa; Male; Mice; Middle Aged; Mitochondria; Mutation; Parkinsonian Disorders; Pedigree; Polyneuropathies | 2020 |
Acute motor axonal polyneuropathy in one parkinsonian patient receiving moderate dosage of oral levodopa.
Topics: Antiparkinson Agents; Humans; Levodopa; Parkinson Disease; Polyneuropathies | 2021 |
Consideration about "Polyneuropathy in levodopa-treated Parkinson's patients".
Topics: Antiparkinson Agents; Humans; Levodopa; Parkinson Disease; Polyneuropathies | 2017 |
Central conduction abnormalities in patients receiving levodopa-carbidopa intestinal gel infusion.
Topics: Aged; Antiparkinson Agents; Carbidopa; Central Nervous System; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Neural Conduction; Parkinson Disease; Peripheral Nervous System; Polyneuropathies; Prospective Studies | 2017 |
Correlations Between Methionine Cycle Metabolism, COMT Genotype, and Polyneuropathy in L-Dopa Treated Parkinson's Disease: A Preliminary Cross-Sectional Study.
Topics: Aged; Catechol O-Methyltransferase; Cognition Disorders; Cross-Sectional Studies; Female; Genotype; Homocysteine; Humans; Levodopa; Male; Methionine; Middle Aged; Neuropsychological Tests; Parkinson Disease; Polymorphism, Single Nucleotide; Polyneuropathies; Statistics, Nonparametric; Vitamins | 2017 |
Increased Prevalence of Polyneuropathy in Parkinson's Disease Patients: An Observational Study.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Case-Control Studies; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polyneuropathies; Prevalence; Vitamin B 12 Deficiency | 2018 |
The influence of levodopa, entacapone and homocysteine on prevalence of polyneuropathy in patients with Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Case-Control Studies; Catechols; Female; Homocysteine; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Polyneuropathies; Statistics, Nonparametric | 2018 |
Severe ataxic polyneuropathy associated with chronic levodopa use in Parkinson's disease.
Topics: Adult; Biopsy; Humans; Levodopa; Middle Aged; Parkinson Disease; Polyneuropathies; Treatment Outcome | 2013 |
Neuropathy in Parkinson's disease patients with intestinal levodopa infusion versus oral drugs.
Topics: Administration, Oral; Aged; Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Female; Gels; Humans; Infusions, Parenteral; Intestines; Levodopa; Male; Middle Aged; Patient Outcome Assessment; Polyneuropathies; Prospective Studies; Weight Loss | 2013 |
Subacute peripheral neuropathy under duodopa therapy without cobalamin deficiency and despite supplementation.
Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Humans; Infusions, Parenteral; Jejunum; Levodopa; Male; Parkinson Disease; Polyneuropathies; Vitamin B 12 | 2014 |
Polyneuropathy in levodopa-treated Parkinson's patients.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polyneuropathies; Risk Factors; Severity of Illness Index | 2016 |
Clinical correlates of sural neurography impairment within normal limits in patients with Parkinsons disease.
Topics: Adult; Aged; Axons; Electric Stimulation; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polyneuropathies | 2017 |
Neuropathy as a potential complication of levodopa use in Parkinson's disease: a pharmacological and pharmacovigilance point of view.
Topics: Antiparkinson Agents; Databases, Factual; Humans; Levodopa; Parkinson Disease; Polyneuropathies | 2010 |
Neuropathy in idiopathic Parkinson disease: an iatrogenic problem?
Topics: Humans; Iatrogenic Disease; Levodopa; Parkinson Disease; Polyneuropathies | 2011 |
Malnutritional neuropathy under intestinal levodopa infusion.
Topics: Aged; Carbidopa; Humans; Infusions, Parenteral; Levodopa; Male; Malnutrition; Middle Aged; Neurotoxicity Syndromes; Parkinson Disease; Polyneuropathies | 2012 |
Is chronic levodopa therapy associated with distal symmetric polyneuropathy in Parkinson's disease?
Topics: Adult; Aged; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polyneuropathies; Prevalence | 2013 |
[Follow-up study after enteral manganese poisoning: clinical, laboratory and neuroradiological findings].
Topics: Aged; Aged, 80 and over; Brain; Humans; Levodopa; Magnetic Resonance Imaging; Male; Manganese Poisoning; Parkinson Disease, Secondary; Polyneuropathies; Potassium Permanganate; Psychiatric Status Rating Scales; Remission, Spontaneous | 2000 |
Physiological and pharmacological aids in the differential diagnosis of tremor.
Topics: Ataxia; Diagnosis, Differential; Ethanol; Humans; Isoproterenol; Levodopa; Methods; Parkinson Disease; Phenothiazines; Polyneuropathies; Propranolol; Tremor | 1976 |